Company Overview
Snapshot
Founded in January 2016 by Ariel Hasidim, EifoDefi operates with 1–10 employees. The company has secured funding across one disclosed round, with Cactus Capital participating as an investor. EifoDefi is known for its social defibrillator mapping application, which is currently active in Israel.
Business overview
EifoDefi develops a social defibrillator mapping application designed to collaboratively map automated external defibrillators (AEDs) in Israel. The company's core technology is a mobile application that makes public AED locations accessible to everyone, aiming to save lives. EifoDefi operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Accessibility Solutions, serving patients and the broader healthcare market in Israel.
Strategic signal
In February 2022, EifoDefi was featured in a Jerusalem Post article highlighting its mission to map defibrillators and save lives. This coverage underscores the company's ongoing relevance and the critical importance of its technology in public health, signaling continued efforts to expand awareness and adoption of its life-saving solution.
Log in to access full profile ›Company Intelligence Q&A
- What is EifoDefi's primary offering?
- EifoDefi provides a social defibrillator mapping application that enables collaborative mapping of automated external defibrillators (AEDs) to make them accessible to the public.
- When was EifoDefi founded and by whom?
- EifoDefi was founded in January 2016 by Ariel Hasidim, who serves as Co-founder & CEO.
- What is the primary geographic market for EifoDefi's solution?
- EifoDefi's primary geographic market is Israel, where its app is currently in use.
- What is the strategic importance of EifoDefi's mobile application?
- The EifoDefi mobile application is critical for public health, as it allows for the real-time tracking and accessibility of defibrillators, which can be life-saving in cardiac emergencies.